Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
[18F]F-TMP PET/CT Imaging in Bacterial Infections
NCT04263792Phase 1Recruiting
- Sponsor
- University of Pennsylvania
- Start
- Feb 2020
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of [18F]fluoropropyl-trimethoprim in bacterial infection (2 cohorts), sponsored by University of Pennsylvania. Primary endpoints: Biodistribution of F-TMP at 3 years and Kinetics of uptake of [18F]F-TMP at 3 years. Started Feb 2020; status: recruiting.
02
Drugs
[18F]fluoropropyl-trimethoprim
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT04263792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04263792.